Home › Companies › AngioDynamics, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AngioDynamics, Inc.’s Form 8-K, filed November 12, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of November 10, 2025: 4 items on AngioDynamics, Inc.’s Form 8-K, filed November 12, 2025: 2 elected · 2 approved.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore AngioDynamics, Inc. in the interactive database Compare manager voting policies
These tallies are AngioDynamics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed November 12, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: James C. Clemmer | 29,634,152 | -- | -- | 800,454 | 5,462,943 | 97% | Elected | — |
| Elect Director: Michael E. Tarnoff, MD | 29,245,896 | -- | -- | 1,188,710 | 5,462,943 | 96% | Elected | — |
| 2. Proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026 | 35,727,186 | 156,899 | 13,464 | -- | -- | 99.6% | Approved | — |
| 3. Proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers | 28,357,782 | 2,057,982 | 18,842 | -- | 5,462,943 | 93% | Approved | — |
Source: AngioDynamics, Inc., Form 8-K, filed with the SEC on November 12, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
190 asset managers disclosed a vote on at least one AngioDynamics, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Proposal to elect two Class I directors, for a term of three years: James C. Clemmer
AngioDynamics, Inc.’s own tally for this item (“Elect Director: James C. Clemmer”): 29,634,152 for, 800,454 withheld, per its Form 8-K filed November 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Board of Directors were elected, each as a Class I director to serve until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 9,331,457 for, 299 withheld, 1,135 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,076,882 | 0 | 0 | 0 | For |
| BlackRock | 1,612,522 | 0 | 0 | 0 | For |
| TIAA | 1,012,627 | 0 | 0 | 0 | For |
| Fidelity | 991,096 | 0 | 0 | 0 | For |
| Royce | 553,461 | 0 | 0 | 0 | For |
| Dimensional | 499,017 | 0 | 0 | 0 | For |
| Charles Schwab | 330,988 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 322,747 | 0 | 0 | 0 | For |
| Transamerica | 304,000 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 243,221 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 200,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,902 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 119,724 | 0 | 0 | 0 | For |
| Equitable | 104,744 | 0 | 0 | 0 | For |
| American Century | 96,905 | 0 | 0 | 0 | For |
| State Street | 92,051 | 0 | 0 | 124 | For |
| Dunham Funds | 80,807 | 0 | 0 | 0 | For |
| 1290 Funds | 72,465 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 69,058 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,995 | 0 | 0 | 0 | For |
| Goldman Sachs | 54,264 | 0 | 0 | 0 | For |
| SEI | 51,777 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,109 | 0 | 0 | 0 | For |
| Northern Trust | 25,376 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,054 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Proposal to elect two Class I directors, for a term of three years: Michael E. Tarnoff, MD
AngioDynamics, Inc.’s own tally for this item (“Elect Director: Michael E. Tarnoff, MD”): 29,245,896 for, 1,188,710 withheld, per its Form 8-K filed November 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Board of Directors were elected, each as a Class I director to serve until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 9,319,940 for, 11,816 withheld, 1,135 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,076,882 | 0 | 0 | 0 | For |
| BlackRock | 1,612,522 | 0 | 0 | 0 | For |
| TIAA | 1,012,627 | 0 | 0 | 0 | For |
| Fidelity | 991,096 | 0 | 0 | 0 | For |
| Royce | 553,461 | 0 | 0 | 0 | For |
| Dimensional | 499,017 | 0 | 0 | 0 | For |
| Charles Schwab | 330,988 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 322,747 | 0 | 0 | 0 | For |
| Transamerica | 304,000 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 243,221 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 200,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,902 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 119,724 | 0 | 0 | 0 | For |
| Equitable | 104,744 | 0 | 0 | 0 | For |
| American Century | 96,905 | 0 | 0 | 0 | For |
| State Street | 92,051 | 0 | 0 | 124 | For |
| Dunham Funds | 80,807 | 0 | 0 | 0 | For |
| 1290 Funds | 72,465 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 69,058 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,995 | 0 | 0 | 0 | For |
| Goldman Sachs | 54,264 | 0 | 0 | 0 | For |
| SEI | 51,777 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,109 | 0 | 0 | 0 | For |
| Northern Trust | 25,376 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,054 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
93% Approved · of votes cast
Prior year: 95.4% for (November 12, 2024 meeting) ▼ 2.2 pts
Description as filed by funds: Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers.
AngioDynamics, Inc.’s own tally for this item (“3. The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers”): 28,357,782 for, 2,057,982 against — passed, per its Form 8-K filed November 12, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers was approved based upon the following votes:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,076,882 | 0 | 0 | 0 | For |
| BlackRock | 1,612,522 | 0 | 0 | 0 | For |
| TIAA | 1,012,627 | 0 | 0 | 0 | For |
| Fidelity | 991,096 | 0 | 0 | 0 | For |
| Royce | 553,461 | 0 | 0 | 0 | For |
| Dimensional | 499,017 | 0 | 0 | 0 | For |
| Charles Schwab | 330,988 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 322,747 | 0 | 0 | 0 | For |
| Transamerica | 304,000 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 243,221 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 200,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,902 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 119,724 | 0 | 0 | 0 | For |
| Equitable | 104,744 | 0 | 0 | 0 | For |
| American Century | 0 | 96,905 | 0 | 0 | Against |
| State Street | 92,175 | 0 | 0 | 0 | For |
| Dunham Funds | 80,807 | 0 | 0 | 0 | For |
| 1290 Funds | 72,465 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 69,058 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,995 | 0 | 0 | 0 | For |
| Goldman Sachs | 54,264 | 0 | 0 | 0 | For |
| SEI | 51,777 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,109 | 0 | 0 | 0 | For |
| Northern Trust | 25,376 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,054 | 0 | 0 | 0 | For |
Fund voting reports, all 53 managers: 9,228,306 for, 104,585 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Point72 | 2,090,346 | 0 | 0 | 0 | For |
| BlackRock | 1,548,490 | 400 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 1,432,100 | 0 | 0 | 0 | For |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 1,383,060 | 12,605 | 0 | 0 | For |
| Divisadero Street Capital Management, LP | 1,387,470 | 0 | 0 | 0 | For |
| Nuveen | 1,015,147 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 987,473 | 0 | 0 | 0 | For |
| SEGALL BRYANT & HAMILL, LLC | 939,525 | 0 | 0 | 0 | For |
| State Street | 841,349 | 0 | 0 | 0 | For |
| Renaissance | 666,025 | 0 | 0 | 0 | For |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 518,200 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 517,284 | 0 | 0 | Against |
| Pier Capital, LLC | 453,953 | 0 | 0 | 0 | For |
| Royce | 438,899 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 408,061 | 0 | 0 | 0 | For |
| Manatuck Hill Partners, LLC | 333,058 | 0 | 0 | 0 | For |
| Charles Schwab | 331,038 | 0 | 0 | 0 | For |
| Invesco | 0 | 314,742 | 0 | 0 | Against |
| Orion Porfolio Solutions, LLC | 289,390 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 277,335 | 0 | 0 | 0 | For |
| Northern Trust | 269,580 | 0 | 0 | 0 | For |
| Two Sigma | 199,707 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 196,158 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 194,713 | 0 | 0 | 0 | For |
| MOORE CAPITAL MANAGEMENT, LP | 190,675 | 0 | 0 | 0 | For |
Institutional-manager reports, all 148 managers: 18,787,519 for, 952,489 against, 1,594 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Prior year: 99.5% for (November 12, 2024 meeting) unchanged
Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as AngioDynamics, Inc. independent registered public accounting firm for the fiscal year ending May 31, 2026.
AngioDynamics, Inc.’s own tally for this item (“2. The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026”): 35,727,186 for, 156,899 against — passed, per its Form 8-K filed November 12, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026 was approved based upon the following votes:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 9,329,848 for, 3,043 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,076,882 | 0 | 0 | 0 | For |
| BlackRock | 1,612,522 | 0 | 0 | 0 | For |
| TIAA | 1,012,627 | 0 | 0 | 0 | For |
| Fidelity | 991,096 | 0 | 0 | 0 | For |
| Royce | 553,461 | 0 | 0 | 0 | For |
| Dimensional | 499,017 | 0 | 0 | 0 | For |
| Charles Schwab | 330,988 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 322,747 | 0 | 0 | 0 | For |
| Transamerica | 304,000 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 243,221 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 200,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,902 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 119,724 | 0 | 0 | 0 | For |
| Equitable | 104,744 | 0 | 0 | 0 | For |
| American Century | 96,905 | 0 | 0 | 0 | For |
| State Street | 92,175 | 0 | 0 | 0 | For |
| Dunham Funds | 80,807 | 0 | 0 | 0 | For |
| 1290 Funds | 72,465 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 69,058 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,995 | 0 | 0 | 0 | For |
| Goldman Sachs | 54,264 | 0 | 0 | 0 | For |
| SEI | 50,044 | 1,733 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,109 | 0 | 0 | 0 | For |
| Northern Trust | 25,376 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,054 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 41,004,249 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.07% |
| 2 | BlackRock | 3.93% |
| 3 | TIAA | 2.47% |
| 4 | Fidelity | 2.42% |
| 5 | Royce | 1.35% |
| 6 | Dimensional | 1.22% |
| 7 | Charles Schwab | 0.81% |
| 8 | Segall Bryant & Hamill Trust | 0.79% |
| 9 | Transamerica | 0.74% |
| 10 | FIRST EAGLE FUNDS | 0.59% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Point72 | 5.10% |
| 2 | BlackRock | 3.78% |
| 3 | ARMISTICE CAPITAL, LLC | 3.49% |
| 4 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 3.40% |
| 5 | Divisadero Street Capital Management, LP | 3.38% |
| 6 | Nuveen | 2.48% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.41% |
| 8 | SEGALL BRYANT & HAMILL, LLC | 2.29% |
| 9 | State Street | 2.05% |
| 10 | Renaissance | 1.62% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 3,685,904 | 8.99% | Form 13F, quarter ended March 31, 2026 |
| Point72 | 3,181,829 | 7.76% | Form 13F, quarter ended March 31, 2026 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,508,295 | 6.12% | Schedule 13G, filed February 10, 2026 |
| Vanguard Group | 2,436,833 | 5.94% | Form 13F, quarter ended March 31, 2026 |
| KEVIN KOTLER | 2,421,526 | 5.91% | Schedule 13G, filed February 9, 2026 |
| State Street | 1,333,858 | 3.25% | Form 13F, quarter ended March 31, 2026 |
| James C. Clemmer | 1,117,665 | 2.73% | Proxy statement (DEF 14A), proxy filed September 25, 2025 |
| Dimensional Fund Advisors | 948,815 | 2.31% | Form 13F, quarter ended March 31, 2026 |
| Renaissance Technologies | 803,283 | 1.96% | Form 13F, quarter ended March 31, 2026 |
| Millennium Management | 644,677 | 1.57% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 41,004,249 shares outstanding, as reported by AngioDynamics, Inc. on its Form 10-Q dated August 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At AngioDynamics, Inc.'s shareholder meeting held November 10, 2025, in the 2025-2026 proxy season, 190 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 801 separate fund positions. On the most widely held item on that ballot — Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. — AngioDynamics, Inc.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AngioDynamics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on November 12, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AngioDynamics, Inc.’s 10-Q dated August 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
AngioDynamics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “AngioDynamics (ANGO) 2025 Annual Meeting (2025-2026 season)”, https://proxyvotesnow.com/company/angiodynamics-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.